{"id":"https://openalex.org/W2616499799","doi":"https://doi.org/10.2174/1567201814666170518131934","title":"Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan","display_name":"Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan","alternate_titles":[],"publication_year":2017,"publication_date":"2017-05-18","ids":{"openalex":"https://openalex.org/W2616499799","doi":"https://doi.org/10.2174/1567201814666170518131934","mag":"2616499799","pmid":"https://pubmed.ncbi.nlm.nih.gov/28521674"},"language":"en","primary_location":{"id":"doi:10.2174/1567201814666170518131934","doi":"https://doi.org/10.2174/1567201814666170518131934","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1567201814666170518131934","pdf_url":null,"source":{"id":"https://openalex.org/S16973894","display_name":"Current Drug Delivery","issn_l":"1567-2018","issn":["1567-2018","1875-5704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Delivery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2616499799"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017365328","display_name":"Abdul Ahad","orcid":"https://orcid.org/0000-0002-8769-4564","observed_orcids":["https://orcid.org/0000-0002-8769-4564"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Abdul Ahad","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015957679","display_name":"Mohammad Raish","orcid":"https://orcid.org/0000-0002-6015-6125","observed_orcids":["https://orcid.org/0000-0002-6015-6125"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Mohammad Raish","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048688773","display_name":"Fahad Ibrahim Al-Jenoobi","orcid":"https://orcid.org/0000-0001-8203-1940","observed_orcids":["https://orcid.org/0000-0001-8203-1940"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Fahad I. Al-Jenoobi","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110404822","display_name":"Abdullah Mohammed Al-Mohizea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Abdullah M. Al-Mohizea","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017365328"],"corresponding_institution_ids":["https://openalex.org/I28022161"],"apc_list":null,"apc_paid":null,"fwci":2.0838,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.82954853,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"15","issue":"2","first_page":"260","last_page":"266"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.8192999958992004,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.8192999958992004,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.121799997985363,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.02419999986886978,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/niosomes","display_name":"niosomes","score":0.9700000286102295},{"id":"https://openalex.org/keywords/telmisartan","display_name":"telmisartan","score":0.9800000190734863},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.9829999804496765},{"id":"https://openalex.org/keywords/sorbitan-monostearate","display_name":"sorbitan monostearate","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cholesterol","display_name":"cholesterol","score":0.9819999933242798},{"id":"https://openalex.org/keywords/angiotensin-ii-type-1-receptor","display_name":"angiotensin II type 1 receptor","score":0.8379999995231628},{"id":"https://openalex.org/keywords/antihypertensive-effect","display_name":"antihypertensive effect","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5189999938011169},{"id":"https://openalex.org/keywords/vesicle-characterization","display_name":"vesicle characterization","score":0.5770000219345093},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.8209999799728394},{"id":"https://openalex.org/keywords/aortic-smooth-muscle","display_name":"aortic smooth muscle","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C72918618","wikidata":"https://www.wikidata.org/wiki/Q1993211","display_name":"Niosome","level":4,"score":0.9818401336669922},{"id":"https://openalex.org/C2779716603","wikidata":"https://www.wikidata.org/wiki/Q733186","display_name":"Telmisartan","level":3,"score":0.9405581951141357},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5494194030761719},{"id":"https://openalex.org/C11432220","wikidata":"https://www.wikidata.org/wiki/Q1975334","display_name":"Dispersity","level":2,"score":0.5383772253990173},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5260517597198486},{"id":"https://openalex.org/C58226133","wikidata":"https://www.wikidata.org/wiki/Q1324199","display_name":"Pulmonary surfactant","level":2,"score":0.5238897204399109},{"id":"https://openalex.org/C130316041","wikidata":"https://www.wikidata.org/wiki/Q189206","display_name":"Vesicle","level":3,"score":0.5141177773475647},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.4884189963340759},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4741891324520111},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.4317502975463867},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.4216834604740143},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3463694155216217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31526291370391846},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.27327561378479004},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2302897870540619},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2209763526916504},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.18431368470191956},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.17882195115089417},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16349563002586365},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.11728894710540771},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.10093888640403748},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.09077709913253784},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07363128662109375},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.061794549226760864},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.06107315421104431},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077333","descriptor_name":"Telmisartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006601","descriptor_name":"Hexoses","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013501","descriptor_name":"Surface-Active Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1567201814666170518131934","doi":"https://doi.org/10.2174/1567201814666170518131934","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1567201814666170518131934","pdf_url":null,"source":{"id":"https://openalex.org/S16973894","display_name":"Current Drug Delivery","issn_l":"1567-2018","issn":["1567-2018","1875-5704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Delivery","raw_type":"journal-article"},{"id":"pmid:28521674","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28521674","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug delivery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4322626970","https://openalex.org/W2311372245","https://openalex.org/W2996633986","https://openalex.org/W7125418974","https://openalex.org/W4312250513","https://openalex.org/W3199862497","https://openalex.org/W4401289141","https://openalex.org/W4386253919","https://openalex.org/W4391469393","https://openalex.org/W4414199365"],"abstract_inverted_index":{"BACKGROUND:":[0],"Niosomes":[1],"are":[2],"non-ionic":[3],"surfactant":[4],"vesicles":[5,66,127],"used":[6],"as":[7,220],"drug":[8],"carriers":[9,222],"for":[10,30,37,65,223],"encapsulating":[11],"both":[12],"hydrophobic":[13],"and":[14,26,35,57,63,82,95,112,141,176,198],"hydrophilic":[15],"drugs.":[16],"The":[17,74,121],"aim":[18],"of":[19,33,79,85,102,129,134,139,172,201,211,217,227],"the":[20,54,150,155,194,215],"present":[21,212],"study":[22,78,147,213],"was":[23,104],"to":[24,169,189,206],"prepare":[25],"characterize":[27],"niosomes":[28,44,123,187,219],"formulations":[29],"oral":[31,225],"delivery":[32,226],"telmisartan":[34,185],"evaluated":[36],"its":[38],"antihypertensive":[39,77],"activity.":[40],"METHOD:":[41],"Telmisartan":[42],"loaded":[43,186],"were":[45],"prepared":[46],"using":[47],"thin":[48],"film":[49],"hydration":[50],"method":[51],"by":[52,106],"varying":[53],"Span":[55],"60":[56],"cholesterol":[58],"at":[59],"several":[60],"molar":[61],"ratios":[62],"characterized":[64],"size,":[67],"polydispersity":[68,132],"index,":[69],"zeta":[70],"potential,":[71],"entrapment":[72,137],"efficiency.":[73],"in":[75,116,159,166,204],"vivo":[76,146],"optimized":[80,122,151],"formulation":[81,124,152],"molecular":[83],"impact":[84],"angiotensin":[86],"II":[87],"type-1":[88],"receptor":[89],"(AT1R)":[90],"messenger":[91],"Ribonucleic":[92],"acid":[93],"(mRNA)":[94],"protein":[96,199],"expression":[97],"on":[98],"smooth":[99],"vascular":[100],"muscles":[101],"aorta":[103],"determined":[105],"real-time":[107],"polymerase":[108],"chain":[109],"reaction":[110],"(RT-PCR)":[111],"western":[113],"blot":[114],"analysis":[115],"Wistar":[117],"albino":[118],"rats.":[119,208],"RESULTS:":[120],"NS6":[125],"presented":[126],"size":[128],"618.47":[130],"nm,":[131],"index":[133],"0.86,":[135],"with":[136],"efficiency":[138],"83.83%":[140],"possesses":[142],"negative":[143],"charge.":[144],"In":[145,183],"showed":[148],"that":[149],"could":[153],"reduce":[154],"systolic":[156,173],"blood":[157,174],"pressure":[158,175],"methyl":[160],"prednisolone":[161],"acetate":[162],"induced":[163],"hypertensive":[164,190,207],"rats":[165,191],"close":[167],"proximity":[168],"normal":[170],"range":[171],"maintain":[177],"it":[178],"over":[179],"an":[180],"extended":[181],"period.":[182],"addition,":[184],"treatment":[188],"significantly":[192],"attenuates":[193],"raised":[195],"mRNA":[196],"level":[197,200],"AT1R":[202],"gene":[203],"comparison":[205],"CONCLUSION:":[209],"Results":[210],"confer":[214],"potential":[216],"developed":[218],"suitable":[221],"improved":[224],"telmisartan.":[228]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2616499799","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-05-26T00:00:00"}
